HB0012 amends Maryland’s Alcoholic Beverages and Cannabis laws and the Criminal Law article to tighten regulation of tetrahydrocannabinol (THC) products, especially intoxicating hemp-derived and other nontraditional cannabinoid products. The bill defines THC broadly to include delta-8, delta-9, delta-10, and other intoxicating cannabinoids, and it prohibits the sale or distribution of products intended for human consumption or inhalation that exceed specified THC limits unless they are sold by a licensed cannabis business and comply with state manufacturing, testing, packaging, and labeling rules. It also creates a narrow exception for certain hemp-derived tinctures that meet a cannabidiol-to-THC ratio and potency limits, subject to testing requirements.
The bill further makes it unlawful to sell or distribute cannabinoid products that are not derived from naturally occurring biologically active chemical constituents, and it bars the sale of products advertised as containing THC in amounts that violate state potency rules. Advertising is defined broadly to include packaging, labeling, and electronic communications. The Executive Director of the Alcohol, Tobacco, and Cannabis Commission is authorized to seize, destroy, or confiscate unlawful products offered for sale in unlicensed locations, and non-licensees who violate the new provisions may be charged by citation and face misdemeanor penalties and fines up to $5,000. Licensed cannabis businesses that violate the rules are subject to administrative discipline.
The bill also expands enforcement authority for the Field Enforcement Division of the Commission by allowing officers and employees to issue citations or other charging documents for violations of Criminal Law § 10-108. In addition, it amends that section to treat the display or offering of THC for sale as prima facie evidence of unlawful sale, similar to existing rules for alcoholic beverages. The Criminal Law section already prohibits sales of delta-8 and delta-10 THC products to persons under 21, and those age-verification requirements remain in place.
Overall, the bill’s impact is to strengthen Maryland’s regulatory framework for intoxicating hemp and THC products, align enforcement tools with the state’s cannabis licensing system, and give regulators more direct authority over products sold outside licensed channels. It affects retailers, hemp product sellers, cannabis licensees, and online sellers by imposing stricter potency, packaging, labeling, age-restriction, and enforcement standards. It also creates a clearer legal basis for enforcement against products marketed as THC-containing but sold in ways that do not comply with cannabis law.
No committee transcript or vote record was provided, so the available context does not show debate or recorded support/opposition. Based on the bill text alone, the measure appears primarily enforcement-oriented and regulatory rather than controversial in structure, but it does draw a line between licensed cannabis commerce and unlicensed hemp-derived intoxicating products, which is the most likely area of contention for affected businesses and industry stakeholders.
HB0012 amends the Alcoholic Beverages and Cannabis Article and Criminal Law Article to regulate intoxicating THC products more tightly, including delta-8, delta-9, delta-10, and other cannabinoids. It authorizes citation-based enforcement by the Field Enforcement Division, creates seizure/destruction authority for unlawful products, establishes misdemeanor penalties and fines for non-licensees, and subjects licensees to administrative discipline. It also reinforces age restrictions and online age-verification requirements for THC products.
No committee discussion or vote history was provided, so there is no documented public sentiment in the supplied materials. From the bill text, the measure appears to reflect a regulatory and enforcement-focused approach with a clear policy goal of restricting unlicensed THC products and protecting minors, suggesting likely support from enforcement and public health interests. Potential resistance would most likely come from hemp retailers, cannabinoid product sellers, and other businesses affected by the tighter potency and advertising restrictions.
The main point of contention is likely the bill’s broad definition of tetrahydrocannabinol and its restrictions on products that contain or are advertised as containing THC, especially for hemp-derived and intoxicating cannabinoid products sold outside the licensed cannabis system. Businesses may object to the potency thresholds, the advertising rule that includes packaging and electronic communications, and the authority to seize products from unlicensed locations. Another likely issue is the distinction between licensed cannabis operators, who face administrative discipline, and non-licensees, who face criminal citation and fines.